Biography

<< Back
John F. Kelly
Director

John F. Kelly has served as a director since May 2024. He retired in June 2022 after a 40-year career at Pfizer Inc., where he was a member of the Pfizer Global Supply Leadership Team and the Pfizer PAC Board of Directors. He concluded his Pfizer career as Vice President, Quality Operations and Environment, Health & Safety, with responsibilities spanning pharmaceutical and consumer product operations, manufacturing strategy, business development, quality and environmental, health and safety matters. Mr. Kelly served as Chair of the board of Zydus Cadila Oncology Private Limited, a Pfizer joint venture, from March 2019 to June 2022, after serving as a director from December 2015. He is Chair of the Board of Trustees of Wakeman Boys & Girls Club and a member of the Worcester Polytechnic Institute Engineering Dean’s Advisory Board. Mr. Kelly earned a degree in Chemical Engineering from Worcester Polytechnic Institute and an M.B.A. in Operations Management from Pace University.

  • Nominating and Corporate Governance Committee
  • Compensation and Talent Management Committee

Primary IR Contact

Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819

Transfer Agent

Equiniti Trust Company, LLC
28 Liberty Street, Floor 53
New York, NY 10005
Telephone: (800) 937-5449
Outside U.S. & Canada:
(718) 921-8124 
HelpAST@equiniti.com
https://www.astfinancial.com

Overnight address
For shareholder request:

Equiniti Trust Company, LLC 
ATTN: EQ – Automated Scanning Team
1110 Centre Pointe Curve, Suite 101
Mendota Heights, Minnesota 55120-4100
 

 

Subscribe

Stay up to date with investor news, stock information and SEC filings.
Subscribe »